Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2016

Open Access 01-12-2016 | Research

Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population

Authors: Hisham Megahed, Michaël Nicouleau, Giulia Barcia, Daniel Medina-Cano, Karine Siquier-Pernet, Christine Bole-Feysot, Mélanie Parisot, Cécile Masson, Patrick Nitschké, Marlène Rio, Nadia Bahi-Buisson, Isabelle Desguerre, Arnold Munnich, Nathalie Boddaert, Laurence Colleaux, Vincent Cantagrel

Published in: Orphanet Journal of Rare Diseases | Issue 1/2016

Login to get access

Abstract

Background

Cerebellar atrophy and developmental delay are commonly associated features in large numbers of genetic diseases that frequently also include epilepsy. These defects are highly heterogeneous on both the genetic and clinical levels. Patients with these signs also typically present with non-specific neuroimaging results that can help prioritize further investigation but don’t suggest a specific molecular diagnosis.

Methods

To genetically explore a cohort of 18 Egyptian families with undiagnosed cerebellar atrophy identified on MRI, we sequenced probands and some non-affected family members via high-coverage whole exome sequencing (WES; >97 % of the exome covered at least by 30x). Patients were mostly from consanguineous families, either sporadic or multiplex. We analyzed WES data and filtered variants according to dominant and recessive inheritance models.

Results

We successfully identified disease-causing mutations in half of the families screened (9/18). These mutations are located in seven different genes, PLA2G6 being the gene most frequently mutated (n = 3). We also identified a recurrent de novo mutation in the KIF1A gene and a molybdenum cofactor deficiency caused by the loss of the start codon in the MOCS2A open-reading frame in a mildly affected subject.

Conclusions

This study illustrates the necessity of screening for dominant mutations in WES data from consanguineous families. Our identification of a patient with a mild and improving phenotype carrying a previously characterized severe loss of function mutation also broadens the clinical spectrum associated with molybdenum cofactor deficiency.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boddaert N, Desguerre I, Bahi-Buisson N, Romano S, Valayannopoulos V, Saillour Y, et al. Posterior fossa imaging in 158 children with ataxia. Journal of neuroradiology Journal de neuroradiologie. 2010;37(4):220–50.CrossRefPubMed Boddaert N, Desguerre I, Bahi-Buisson N, Romano S, Valayannopoulos V, Saillour Y, et al. Posterior fossa imaging in 158 children with ataxia. Journal of neuroradiology Journal de neuroradiologie. 2010;37(4):220–50.CrossRefPubMed
4.
go back to reference Romani M, Kraoua I, Micalizzi A, Klaa H, Benrhouma H, Drissi C, et al. Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort. Eur J Neurol. 2015;22(1):178–86. doi:10.1111/ene.12552.CrossRefPubMed Romani M, Kraoua I, Micalizzi A, Klaa H, Benrhouma H, Drissi C, et al. Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort. Eur J Neurol. 2015;22(1):178–86. doi:10.​1111/​ene.​12552.CrossRefPubMed
6.
go back to reference Deciphering Developmental Disorders S. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015;519(7542):223–8. doi:10.1038/nature14135. Deciphering Developmental Disorders S. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015;519(7542):223–8. doi:10.​1038/​nature14135.
9.
go back to reference Kousi M, Lehesjoki AE, Mole SE. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat. 2012;33(1):42–63. doi:10.1002/humu.21624.CrossRefPubMed Kousi M, Lehesjoki AE, Mole SE. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat. 2012;33(1):42–63. doi:10.​1002/​humu.​21624.CrossRefPubMed
11.
go back to reference Ohba C, Osaka H, Iai M, Yamashita S, Suzuki Y, Aida N, et al. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. Neurogenetics. 2013;14(3–4):225–32. doi:10.1007/s10048-013-0375-8.CrossRefPubMed Ohba C, Osaka H, Iai M, Yamashita S, Suzuki Y, Aida N, et al. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. Neurogenetics. 2013;14(3–4):225–32. doi:10.​1007/​s10048-013-0375-8.CrossRefPubMed
13.
go back to reference Lee JR, Srour M, Kim D, Hamdan FF, Lim SH, Brunel-Guitton C, et al. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum Mutat. 2015;36(1):69–78. doi:10.1002/humu.22709.CrossRefPubMed Lee JR, Srour M, Kim D, Hamdan FF, Lim SH, Brunel-Guitton C, et al. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum Mutat. 2015;36(1):69–78. doi:10.​1002/​humu.​22709.CrossRefPubMed
14.
go back to reference Schwahn BC, Van Spronsen FJ, Belaidi AA, Bowhay S, Christodoulou J, Derks TG et al. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study. Lancet. 2015. doi:10.1016/S0140-6736(15)00124-5. Schwahn BC, Van Spronsen FJ, Belaidi AA, Bowhay S, Christodoulou J, Derks TG et al. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study. Lancet. 2015. doi:10.​1016/​S0140-6736(15)00124-5.
15.
go back to reference Leimkuhler S, Freuer A, Araujo JA, Rajagopalan KV, Mendel RR. Mechanistic studies of human molybdopterin synthase reaction and characterization of mutants identified in group B patients of molybdenum cofactor deficiency. J Biol Chem. 2003;278(28):26127–34. doi:10.1074/jbc.M303092200.CrossRefPubMed Leimkuhler S, Freuer A, Araujo JA, Rajagopalan KV, Mendel RR. Mechanistic studies of human molybdopterin synthase reaction and characterization of mutants identified in group B patients of molybdenum cofactor deficiency. J Biol Chem. 2003;278(28):26127–34. doi:10.​1074/​jbc.​M303092200.CrossRefPubMed
16.
go back to reference Arenas M, Fairbanks LD, Vijayakumar K, Carr L, Escuredo E, Marinaki AM. An unusual genetic variant in the MOCS1 gene leads to complete missplicing of an alternatively spliced exon in a patient with molybdenum cofactor deficiency. J Inherit Metab Dis. 2009;32(4):560–9. doi:10.1007/s10545-009-1151-7.CrossRefPubMed Arenas M, Fairbanks LD, Vijayakumar K, Carr L, Escuredo E, Marinaki AM. An unusual genetic variant in the MOCS1 gene leads to complete missplicing of an alternatively spliced exon in a patient with molybdenum cofactor deficiency. J Inherit Metab Dis. 2009;32(4):560–9. doi:10.​1007/​s10545-009-1151-7.CrossRefPubMed
17.
Metadata
Title
Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population
Authors
Hisham Megahed
Michaël Nicouleau
Giulia Barcia
Daniel Medina-Cano
Karine Siquier-Pernet
Christine Bole-Feysot
Mélanie Parisot
Cécile Masson
Patrick Nitschké
Marlène Rio
Nadia Bahi-Buisson
Isabelle Desguerre
Arnold Munnich
Nathalie Boddaert
Laurence Colleaux
Vincent Cantagrel
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2016
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-016-0436-9

Other articles of this Issue 1/2016

Orphanet Journal of Rare Diseases 1/2016 Go to the issue